We are live on ! Find out more
FMS icon

Fresenius Medical Care

160 hedge funds and large institutions have $710M invested in Fresenius Medical Care in 2023 Q4 according to their latest regulatory filings, with 28 funds opening new positions, 45 increasing their positions, 47 reducing their positions, and 15 closing their positions.

New
Increased
Maintained
Reduced
Closed

87% more first-time investments, than exits

New positions opened: 28 | Existing positions closed: 15

8% more funds holding

Funds holding: 148160 (+12)

0.35% more ownership

Funds ownership: 11.27%11.62% (+0.35%)

0% less capital invested

Capital invested by funds: $713M → $710M (-$3.29M)

4% less repeat investments, than reductions

Existing positions increased: 45 | Existing positions reduced: 47

9% less call options, than puts

Call options by funds: $4.18M | Put options by funds: $4.58M

Holders
160
Holders Change
+12
Holders Change %
+8.11%
% of All Funds
2.33%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
28
Increased
45
Reduced
47
Closed
15
Calls
$4.18M
Puts
$4.58M
Net Calls
-$403K
Net Calls Change
+$823K
Name Holding Trade Value Shares
Change
Change in
Stake
US Bancorp
51
US Bancorp
Minnesota
$417K -$39.5K -2,058 -9%
FLAM
52
First Light Asset Management
Minnesota
$406K
VC
53
Veracity Capital
Georgia
$406K +$374K +19,480 New
HighTower Advisors
54
HighTower Advisors
Illinois
$402K -$54.7K -2,850 -13%
VPIM
55
Vanguard Personalized Indexing Management
California
$399K +$9.47K +493 +3%
American Century Companies
56
American Century Companies
Missouri
$387K +$4.38K +228 +1%
WHC
57
Wulff, Hansen & Co
California
$380K
National Bank of Canada
58
National Bank of Canada
Quebec, Canada
$370K -$53.7K -2,797 -14%
TI
59
Tidal Investments
Wisconsin
$339K +$66.3K +3,453 +27%
Simplex Trading
60
Simplex Trading
Illinois
$336K +$6.78K +353 +2%
MHC
61
Meyer Handelman Company
New York
$333K
Point72 Asset Management
62
Point72 Asset Management
Connecticut
$329K +$303K +15,800 New
LPAM
63
Lodestar Private Asset Management
California
$329K -$11.5K -600 -4%
D.E. Shaw & Co
64
D.E. Shaw & Co
New York
$320K +$295K +15,345 New
VNA
65
Valley National Advisers
Pennsylvania
$319K -$9.33K -486 -3%
Jane Street
66
Jane Street
New York
$318K -$2.34M -121,804 -89%
RhumbLine Advisers
67
RhumbLine Advisers
Massachusetts
$316K +$3.84K +200 +1%
EAM
68
Eagle Asset Management
Florida
$310K -$10.6K -551 -4%
Bank of New York Mellon
69
Bank of New York Mellon
New York
$303K -$169K -8,819 -38%
Pathstone Holdings
70
Pathstone Holdings
New Jersey
$301K +$277K +14,436 New
Mercer Global Advisors
71
Mercer Global Advisors
Colorado
$295K +$86.8K +4,522 +47%
GT
72
Glenmede Trust
Pennsylvania
$288K -$31.4K -1,636 -11%
Commonwealth Equity Services
73
Commonwealth Equity Services
Massachusetts
$270K -$24.5K -1,275 -9%
RP
74
Riverwater Partners
Wisconsin
$267K
CIBC Private Wealth Group
75
CIBC Private Wealth Group
Georgia
$253K -$107K -5,593 -32%

FMS Hedge Fund Activity: Q4 2023 in Review

160 of the 6,859 institutional investors tracked by Wall St. Rank reported a position in Fresenius Medical Care (FMS) for Q4 2023, worth a combined $710M — down 0.46% from $713M a quarter earlier.

Buyers outnumbered sellers: 28 funds opened new FMS positions and 15 closed out — a net gain of 13 holders — while 45 added to existing stakes and 47 trimmed.

The largest buyer was Morgan Stanley, adding an estimated $16.5M. The largest seller was Fiduciary Management Inc, cutting an estimated $8.02M.

  • 160 institutional investors held Fresenius Medical Care (FMS) as of Q4 2023, up from 148 in Q3 2023.
  • Funds reported $710M of Fresenius Medical Care stock for Q4 2023, down 0.46% quarter-over-quarter.
  • 28 funds opened new Fresenius Medical Care positions in Q4 2023 and 15 closed out, a net change of +13 holders.
  • The largest Fresenius Medical Care buyer in Q4 2023 was Morgan Stanley, an estimated $16.5M added.
  • The largest Fresenius Medical Care seller in Q4 2023 was Fiduciary Management Inc, an estimated $8.02M sold.

Based on aggregated 13F filings for Q4 2023.